We aimed to determine the growth and safety parameters in newborns fed a goat milk based infant formula (Kabrita) using a randomized double-blind trial, in which a cow milk formula served as a control and a breast fed group as a reference. Healthy term infants (n=304) aged up to 14 days old were recruited from 25 European study centers. Our data demonstrate that Kabrita provides adequate growth, has a good tolerability, and is safe to use in infants.
Want to know more? Click here for more information about this clinical trial
Interested to learn more about our brands and our company? Check out our other news posts!
Ausnutria and our brand Kabrita will be present at the online congres “World of Microbiome” from November 4th till November 6th, 2020. This is the second edition of the World of Microbiome for which you can obtain up to 17 CME credits. The congres focusses on two major topics: pregnancy, birth and infancy and digestive …
Despite the corona crisis, Ausnutria Dairy Corporation Ltd. (Ausnutria) shows continued growth in turnover and result, according to the positive profit alert that the company published this week. The company expects a profit increase of approximately 53 percent to € 38.6 million in the first three months of 2020. Turnover is expected to rise by …
Ausnutria’s newest research on the evolution of infants’ gut microbiota under different feeding regimes. The results show that the microbiota diversity is similar in infants fed human milk, goat milk and cow’s milk formula. This demonstrates that Kabrita supports healthy development of the gut microbiota in infants.